The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 81.
xvii. lappuse
... field will find it can serve as a useful reminder of important points they must not overlook to the detri- ment of their clients ' interests . Those persons facing patent litiga- tion would do well to heed the words of caution expressed ...
... field will find it can serve as a useful reminder of important points they must not overlook to the detri- ment of their clients ' interests . Those persons facing patent litiga- tion would do well to heed the words of caution expressed ...
58. lappuse
... field of patentable subject matter . The words just quoted go back to the Patent Act of 179310 and remained unchanged until the word " art " was replaced by " process " one hun- dred and sixty years later . The four terms used , ( 1 ) ...
... field of patentable subject matter . The words just quoted go back to the Patent Act of 179310 and remained unchanged until the word " art " was replaced by " process " one hun- dred and sixty years later . The four terms used , ( 1 ) ...
714. lappuse
... field are rather the rule than the exception . Why ? Because one of the difficul- ties in protecting pharmaceutical ... field is a high- ly competitive field , the inventor knows he cannot wait too long before he files his patent ...
... field are rather the rule than the exception . Why ? Because one of the difficul- ties in protecting pharmaceutical ... field is a high- ly competitive field , the inventor knows he cannot wait too long before he files his patent ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention